ORIGINAL RESEARCH article
Front. Med.
Sec. Obstetrics and Gynecology
A Risk-Stratified Model for Predicting Endometrial Atypical Hyperplasia and Cancer to Guide Biopsy Decisions in Asymptomatic Postmenopausal Women
Provisionally accepted
- 1The Third Affiliated Hospital of Sun Yat-sen University, Department of Obstetrics and Gynecology,, Guangzhou, China
- 2Sun Yat-Sen University, Guangzhou, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Endometrial atypical hyperplasia (EAH) and endometrial cancer (EC) are increasingly detected in asymptomatic postmenopausal women. This often leads to delayed treatment. Risk stratification remains challenging, and single-factor models may not accurately identify high-risk individuals. This study aimed to develop and validate a multivariable prediction model for identifying EAH or EC in asymptomatic postmenopausal women. Methods: This retrospective cohort study included asymptomatic postmenopausal women with endometrial pathology records from the Third Affiliated Hospital of Sun Yat-sen University, China (2021–2024). Candidate risk factors included demographics, clinical characteristics, and hematological parameters. The primary outcome was a composite of histologically-confirmed EAH or EC. Multivariable Poisson regression with robust variance was then employed to identify independent risk factors for this composite outcome. Risk - stratified models were developed by calculating predicted probabilities for key combinations of risk factors. Results: Among 928 patients (median age: 59 years, IQR (interquartile range): 55–65; median BMI: 23.4 kg/m²), the overall prevalence of EAH and EC was 2.59% (24/928). Key independent risk factors included endometrial thickness (EMT) >8 mm (vs. ≤4 mm: adjusted Relative Risks (aRR) = 11.34, 95% confidence interval (95% CI): 4.35– 39.56; p< 0.001), diabetes (aRR = 2.54, 95% CI: 1.12–5.78; p = 0.026), and platelet count per 10⁹/L increase (aRR = 1.01, 95% CI: 1.01–1.02; p < 0.001). EMT >8 mm was the strongest predictor, with the highest aRR. In the stratified analysis, the combination of EMT >8 mm and diabetes was associated with the highest observed prevalence (33.33%). The risk-stratified model demonstrated clinical utility: using a ≥5% risk threshold, biopsy would be recommended for 17% of patients (sensitivity 70.8%, specificity 84.4%); at a ≥10% threshold, biopsy would be recommended for 4.3% of patients (requiring 3.64 biopsies per true positive case). Discussion: The risk of EAH and EC among asymptomatic postmenopausal women varies significantly based on clinical factors. This risk-stratified modeling approach delivers individualized risk estimates to inform endometrial biopsy decisions, facilitating personalized patient management.
Keywords: endometrial cancer, Endometrial atypical hyperplasia, postmenopausal women, Risk prediction model, Endometrial thickness
Received: 18 Sep 2025; Accepted: 24 Nov 2025.
Copyright: © 2025 Wu, Zhang, Lai, Yang and Wan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Jing Wan
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.